These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 1532243
21. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf. Topol LZ, Marx M, Calothy G, Blair DG. Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484 [Abstract] [Full Text] [Related]
22. High frequency of mas oncogene activation detected in the NIH3T3 tumorigenicity assay. van 't Veer LJ, van den Berg-Bakker LA, Hermens RP, Deprez RL, Schrier PI. Oncogene Res; 1988 Jan; 3(3):247-54. PubMed ID: 3060802 [Abstract] [Full Text] [Related]
23. Identification of a transforming activity suppressing sequence in the c-raf oncogene. Ishikawa F, Sakai R, Ochiai M, Takaku F, Sugimura T, Nagao M. Oncogene; 1988 Dec; 3(6):653-8. PubMed ID: 2577866 [Abstract] [Full Text] [Related]
24. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells. Michieli P, Li W, Lorenzi MV, Miki T, Zakut R, Givol D, Pierce JH. Oncogene; 1996 Feb 15; 12(4):775-84. PubMed ID: 8632899 [Abstract] [Full Text] [Related]
25. Functions of the mos oncogene family and associated gene products. Bold RJ, Hannink M, Donoghue DJ. Cancer Surv; 1986 Feb 15; 5(2):243-55. PubMed ID: 2946405 [Abstract] [Full Text] [Related]
27. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression. Forrest D, Muñoz A, Raynoschek C, Vennström B, Beug H. Oncogene; 1990 Mar 15; 5(3):309-16. PubMed ID: 1969136 [Abstract] [Full Text] [Related]
28. Overexpression of avian or mouse c-jun in primary chick embryo fibroblasts confers a partially transformed phenotype. Castellazzi M, Dangy JP, Mechta F, Hirai S, Yaniv M, Samarut J, Lassailly A, Brun G. Oncogene; 1990 Oct 15; 5(10):1541-7. PubMed ID: 2123532 [Abstract] [Full Text] [Related]
29. Structure and transforming potential of the human cot oncogene encoding a putative protein kinase. Miyoshi J, Higashi T, Mukai H, Ohuchi T, Kakunaga T. Mol Cell Biol; 1991 Aug 15; 11(8):4088-96. PubMed ID: 2072910 [Abstract] [Full Text] [Related]
30. Hamster cell line suitable for transfection assay of transforming genes. Higashi T, Sasai H, Suzuki F, Miyoshi J, Ohuchi T, Takai S, Mori T, Kakunaga T. Proc Natl Acad Sci U S A; 1990 Apr 15; 87(7):2409-13. PubMed ID: 2181436 [Abstract] [Full Text] [Related]
34. The role of non-ras transforming genes in chemical carcinogenesis. Cooper CS. Environ Health Perspect; 1991 Jun 15; 93():33-40. PubMed ID: 1685444 [Abstract] [Full Text] [Related]
38. Analysis of the transforming potential of the human homolog of mos. Blair DG, Oskarsson MK, Seth A, Dunn KJ, Dean M, Zweig M, Tainsky MA, Vande Woude GF. Cell; 1986 Aug 29; 46(5):785-94. PubMed ID: 2874888 [Abstract] [Full Text] [Related]
39. Function-dependent cooperation between oncogene activation and nonrandom chromosome change during tumorigenic conversion of Syrian hamster cells. Suzuki K, Miyoshi J, Watanabe M. Cancer Genet Cytogenet; 1994 Jul 01; 75(1):51-9. PubMed ID: 8039164 [Abstract] [Full Text] [Related]
40. Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Gonsky R, Herman V, Melmed S, Fagin J. Mol Endocrinol; 1991 Nov 01; 5(11):1687-95. PubMed ID: 1779971 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]